CHEMUNG FINANCIAL CORP
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
CHMG$86.290.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| CHEMUNG FINANCIAL CORPORATION AND SUBSIDIARIES | ||
|---|---|---|
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
| (UNAUDITED) | ||
| (in thousands) | Three Months Ended March 31, | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | 2025 | 2024 |
| Net income | $6,023 | $7,050 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| (Increases in) amortization of right-of-use assets | 194 | (370) |
| Provision (credit) for credit losses | 1,092 | (2,040) |
| Losses (gains) on disposal of fixed assets, net | 14 | (27) |
| Depreciation and amortization of fixed assets | 467 | 465 |
| Amortization of premiums on securities, net | 510 | 510 |
| (Gains) on sales of loans held for sale, net | (40) | (32) |
| Proceeds from sales of loans held for sale | 2,022 | 1,677 |
| Loans originated and held for sale | (2,266) | (1,741) |
| Losses on sale of other real estate owned, net | 11 | — |
| Change in fair value of equity investments, net | 47 | (101) |
| Proceeds from sales of equity investments | 39 | 89 |
| Purchase of equity investments | (100) | (35) |
| (Increase) decrease in other assets and accrued interest receivable | (467) | 926 |
| (Decrease) increase in accrued interest payable | (56) | 1,920 |
| Expense related to restricted stock units for directors' deferred compensation plan | 6 | 5 |
| Expense related to employee restricted stock awards | 294 | 308 |
| Increases in (payments on) operating lease liabilities | (193) | 370 |
| (Gains) losses on interest rate swaps, net | 61 | (34) |
| Decrease in other liabilities | (470) | (997) |
| Income from bank owned life insurance | (8) | (9) |
| Net cash provided by operating activities | 7,180 | 7,934 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from maturities, calls, and principal paydowns on securities available for sale | 13,635 | 11,942 |
| Purchases of FHLBNY and FRBNY stock | (8,244) | (10,894) |
| Redemption of FHLBNY and FRBNY stock | 9,321 | 12,321 |
| Proceeds from sales of fixed assets | — | 31 |
| Purchases of premises and equipment | (328) | (81) |
| Proceeds from sale of other real estate owned | 158 | — |
| Net increase in loans | (26,175) | (31,185) |
| Net cash used in investing activities | (11,633) | (17,866) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Net increase in demand, interest-bearing demand, savings, and insured money market deposits | 61,510 | 34,250 |
| Net (decrease) increase in time deposits | (24,997) | 17,095 |
| Net change in FHLBNY advances | (24,110) | (31,920) |
| Increases in (payments on) finance leases | (78) | (71) |
| Proceeds from FRB advances | — | 50,000 |
| Purchase of treasury stock | (85) | (82) |
| Sale of treasury stock | 146 | 145 |
| Cash dividends paid | (1,533) | (1,470) |
| Net cash provided by financing activities | 10,853 | 67,947 |
| Net increase in cash and cash equivalents | 6,400 | 58,015 |
| Cash and cash equivalents, beginning of period | 47,035 | 36,847 |
| Cash and cash equivalents, end of period | $53,435 | $94,862 |
CONSOLIDATED STATEMENTS OF CASH FLOWS, CONTINUED
| (in thousands) | Three Months Ended March 31, | |
|---|---|---|
| Supplemental disclosure of cash flow information: | 2025 | 2024 |
| Cash paid for: | ||
| Interest | $11,937 | $11,210 |
| Income taxes | 443 | 459 |
| Supplemental disclosure of non-cash activity: | ||
| Transfer of loans to other real estate owned | — | 233 |
| Dividends declared, not yet paid | — | 1,473 |
| Right-of-use assets obtained through operating lease liabilities | 80 | 570 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.